Related Experiment Video
Updated: Jul 18, 2025
06:03
Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
1.3K
Three is better than two: humoral response in allogeneic HSCT after the third BNT162b2 SARS-CoV-2 mRNA vaccine
L Barabino1, A Galitzia, R Murru
1Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy. luca.barabino@hotmail.com.
European Review for Medical and Pharmacological Sciences
|August 22, 2023
Abstract
No abstract available in PubMed .
More Related Videos
08:52Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
17.3K
11:55Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
Published on: March 14, 2011
14.6K
Related Concept Videos
01:36Humoral Immune Responses
73.0K
Overview
73.0K
01:40Cell-mediated Immune Responses
68.9K
Overview
68.9K
01:51Vaccinations
44.7K
Overview
44.7K
01:31Hybridoma Technology
14.9K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.9K